The companies that bet the most on innovation: amount spent on research and development during the fiscal year 2011.
| # | Enterprise | Market | Sector | R&D expenses (USD) |
|---|---|---|---|---|
| 1 | 🇺🇸United States | Healthcare | 22,79 billion $ | |
| 2 | 🇨🇭Europe | Healthcare | 10,15 billion $8,33 Bn CHF | |
| 3 | 🇨🇭Europe | Healthcare | 9,58 billion $ | |
| 4 | 🇺🇸United States | Technology | 9,04 billion $ | |
| 5 | 🇺🇸United States | Healthcare | 8,47 billion $ | |
| 6 | 🇺🇸United States | Technology | 8,35 billion $ | |
| 7 | 🇩🇪Germany | Consumer Cyclical | 8,06 billion $7,23 Md€ | |
| 8 | 🇺🇸United States | Healthcare | 8,00 billion $ | |
| 9 | 🇺🇸United States | Healthcare | 7,55 billion $ | |
| 10 | 🇰🇷Korea | Technology | 6,80 billion $9 268 Md₩ | |
| 11 | 🇺🇸United States | Technology | 6,26 billion $ | |
| 12 | 🇫🇮Europe | Technology | 6,26 billion $5,61 Md€ | |
| 13 | 🇺🇸United States | Technology | 5,82 billion $ | |
| 14 | 🇫🇷France | Healthcare | 5,36 billion $4,81 Md€ | |
| 15 | 🇺🇸United States | Technology | 5,16 billion $ | |
| 16 | 🇺🇸United States | Healthcare | 5,02 billion $ | |
| 17 | 🇬🇧United Kingdom | Healthcare | 4,92 billion $3,69 Bn£ | |
| 18 | 🇩🇪Germany | Consumer Cyclical | 4,65 billion $4,17 Md€ | |
| 19 | 🇯🇵Japan | Consumer Cyclical | 4,61 billion $730,34 Bn¥ | |
| 20 | 🇺🇸United States | Technology | 4,52 billion $ | |
| 21 | 🇬🇧United Kingdom | Healthcare | 4,36 billion $ | |
| 22 | 🇩🇪Germany | Industrials | 4,35 billion $3,90 Md€ | |
| 23 | 🇺🇸United States | Healthcare | 4,06 billion $ | |
| 24 | 🇩🇪Germany | Consumer Cyclical | 4,02 billion $3,61 Md€ | |
| 25 | 🇺🇸United States | Industrials | 3,92 billion $ | |
| 26 | 🇺🇸United States | Healthcare | 3,84 billion $ | |
| 27 | 🇳🇱Europe | Industrials | 3,51 billion $3,15 Md€ | |
| 28 | 🇸🇪Europe | Technology | 3,30 billion $32,64 billion SEK | |
| 29 | 🇺🇸United States | Healthcare | 3,29 billion $ | |
| 30 | 🇩🇪Germany | Healthcare | 3,27 billion $2,93 Md€ | |
| 31 | 🇺🇸United States | Technology | 3,25 billion $ | |
| 32 | 🇺🇸United States | Healthcare | 3,17 billion $ | |
| 33 | 🇯🇵Japan | Consumer Cyclical | 3,08 billion $487,59 Bn¥ | |
| 34 | 🇺🇸United States | Technology | 3,00 billion $ | |
| 35 | 🇺🇸United States | Consumer Cyclical | 2,91 billion $ | |
| 36 | 🇯🇵Japan | Technology | 2,69 billion $426,81 Bn¥ | |
| 37 | 🇯🇵Japan | Industrials | 2,60 billion $412,51 Bn¥ | |
| 38 | 🇺🇸United States | Technology | 2,43 billion $ | |
| 39 | 🇳🇱Europe | Technology | 2,35 billion $ | |
| 40 | 🇺🇸United States | Industrials | 2,30 billion $ | |
| 41 | 🇫🇷France | Consumer Cyclical | 2,26 billion $2,03 Md€ | |
| 42 | 🇩🇪Germany | Technology | 2,16 billion $1,94 Md€ | |
| 43 | 🇳🇱Europe | Consumer Cyclical | 2,09 billion $1,87 Md€ | |
| 44 | 🇺🇸United States | Industrials | 1,95 billion $ | |
| 45 | 🇯🇵Japan | Technology | 1,94 billion $307,80 Bn¥ | |
| 46 | 🇺🇸United States | Industrials | 1,80 billion $ | |
| 47 | 🇳🇱Europe | Healthcare | 1,79 billion $1,61 Md€ | |
| 48 | 🇩🇪Germany | Consumer Cyclical | 1,79 billion $1,61 Md€ | |
| 49 | 🇩🇪Germany | Basic Materials | 1,79 billion $1,60 Md€ | |
| 50 | 🇯🇵Japan | Healthcare | 1,78 billion $281,88 Bn¥ | |
| 51 | 🇨🇭Europe | Consumer Defensive | 1,73 billion $1,42 Bn CHF | |
| 52 | 🇺🇸United States | Technology | 1,72 billion $ | |
| 53 | 🇯🇵Japan | Communication Services | 1,69 billion $268,22 Bn¥ | |
| 54 | 🇩🇪Germany | Healthcare | 1,69 billion $1,51 Md€ | |
| 55 | 🇧🇷Others | Basic Materials | 1,67 billion $ | |
| 56 | 🇺🇸United States | Basic Materials | 1,65 billion $ | |
| 57 | 🇺🇸United States | Industrials | 1,57 billion $ | |
| 58 | 🇬🇧United Kingdom | Industrials | 1,53 billion $1,15 Bn£ | |
| 59 | 🇳🇱Europe | Consumer Cyclical | 1,52 billion $1,37 Md€ | |
| 60 | 🇮🇪Europe | Healthcare | 1,51 billion $ | |
| 61 | 🇧🇷Others | Energy | 1,45 billion $ | |
| 62 | 🇺🇸United States | Technology | 1,45 billion $ | |
| 63 | 🇩🇰Europe | Healthcare | 1,44 billion $9,63 Bn DKK | |
| 64 | 🇨🇭Europe | Industrials | 1,37 billion $ | |
| 65 | 🇨🇦Canada | Technology | 1,35 billion $ | |
| 66 | 🇸🇪Europe | Industrials | 1,34 billion $13,28 billion SEK | |
| 67 | 🇨🇳China | Technology | 1,27 billion $8,49 billion CN¥ | |
| 68 | 🇨🇳China | Industrials | 1,27 billion $8,47 billion CN¥ | |
| 69 | 🇹🇼Taiwan | Technology | 1,25 billion $40,85 Bn NT$ | |
| 70 | 🇰🇷Korea | Technology | 1,25 billion $1 699 Md₩ | |
| 71 | 🇺🇸United States | Consumer Cyclical | 1,24 billion $ | |
| 72 | 🇺🇸United States | Healthcare | 1,23 billion $ | |
| 73 | 🇯🇵Japan | Healthcare | 1,23 billion $194,33 Bn¥ | |
| 74 | 🇺🇸United States | Industrials | 1,23 billion $ | |
| 75 | 🇺🇸United States | Healthcare | 1,22 billion $ | |
| 76 | 🇺🇸United States | Communication Services | 1,20 billion $ | |
| 77 | 🇯🇵Japan | Technology | 1,15 billion $182,50 Bn¥ | |
| 78 | 🇬🇧United Kingdom | Energy | 1,12 billion $ | |
| 79 | 🇺🇸United States | Technology | 1,12 billion $ | |
| 80 | 🇺🇸United States | Technology | 1,11 billion $176,51 Bn¥ | |
| 81 | 🇮🇱Others | Healthcare | 1,09 billion $ | |
| 82 | 🇺🇸United States | Energy | 1,07 billion $ | |
| 83 | 🇺🇸United States | Industrials | 1,04 billion $165,30 Bn¥ | |
| 84 | 🇺🇸United States | Technology | 1,03 billion $ | |
| 85 | 🇹🇼Taiwan | Technology | 1,03 billion $33,83 Bn NT$ | |
| 86 | 🇺🇸United States | Healthcare | 1,02 billion $ | |
| 87 | 🇺🇸United States | Healthcare | 1,01 billion $159,23 Bn¥ | |
| 88 | 🇺🇸United States | Healthcare | 946,0 M$ | |
| 89 | 🇺🇸United States | Technology | 897,6 M$ | |
| 90 | 🇺🇸United States | Healthcare | 895,0 M$ | |
| 91 | 🇯🇵Japan | Industrials | 876,3 M$138,83 Bn¥ | |
| 92 | 🇮🇪Europe | Technology | 875,0 M$ | |
| 93 | 🇧🇪Europe | Healthcare | 869,6 M$780,0 M€ | |
| 94 | 🇺🇸United States | Technology | 862,0 M$ | |
| 95 | 🇨🇳China | Consumer Cyclical | 858,3 M$5,73 billion CN¥ | |
| 96 | 🇺🇸United States | Technology | 848,8 M$ | |
| 97 | 🇯🇵Japan | Basic Materials | 844,8 M$133,83 Bn¥ | |
| 98 | 🇫🇷France | Consumer Defensive | 803,3 M$720,5 M€ | |
| 99 | 🇺🇸United States | Technology | 791,0 M$ | |
| 100 | 🇫🇷France | Industrials | 783,7 M$703,0 M€ |
⚠ Ranking provided for information purposes, based on public data. It does not constitute investment advice. Values may contain source errors and change with financial publications.